Needle-free program creates a potential second development pathway alongside Valion's injectable Entolimod programNext study will test whether the formulation delivers...
Vivalink's survey of more than 150 adults with cardiac conditions emphasizes the demand for flexible, home-based cardiac rehabilitation programs. Insurance...
Toronto, Ontario--(Newsfile Corp. - September 29, 2026) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Ian Mortimer,...
Toronto, Ontario--(Newsfile Corp. - September 29, 2026) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Ian Mortimer,...
Filament has shipped PEX010 to the University of Calgary for PsiPTSD, a Phase 2 trial of psilocybin-assisted therapy for post-traumatic...
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and...
– KO-7246 regenerated functional β-cell mass and produced durable glycemic control in Type 1 and Type 2 diabetes models –...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
WINNIPEG, MB / ACCESS Newswire / September 28, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company...
New framework aims to turn fragmented scientific data into trusted, evidence-backed intelligence for enterprise AI.Next generation of scientific AI will...
Interventional cardiologist shares real-world experience using intracardiac echocardiography to guide transcatheter tricuspid valve replacement during a physician education program in...
SHELTON, CT / ACCESS Newswire / September 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Half-year ReportInterim Results for the period ended 30 June 2026 LONDON, UK / ACCESS Newswire / September 28, 2026 /...
PUNE, India, Sept. 25, 2026 /PRNewswire/ -- The Global AI in Clinical Trials Market was valued at USD 2 Billion in...
Following authorization of the TEMPO trial under the European Union Clinical Trials Regulation, Filament has expanded its supply agreement with...
SAN DIEGO, Sept. 24, 2026 /PRNewswire/ -- Recently, ACROBiosystems unveiled its latest innovation portfolio—ACRO AIx, CHO-Direct and GlobalLifeShip cross border supply...
NORTH CANTON, Ohio, Sept. 24, 2026 /PRNewswire/ -- The Collegiate Inventors Competition®, an annual competition that has rewarded innovations, discoveries...
~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~...